[New perspectives for injectable contraceptives].
v Kesserü
E
E
1a Cátedra de Ginecología, Universidad de Buenos Aires, Argentina.
D000293:Adolescent; D000328:Adult; D000814:Aniline Compounds / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D050356:Lipid Metabolism; D009640:Norethindrone / Q000008:administration & dosage / Q000031:analogs & derivatives; D011247:Pregnancy
D000814:Aniline Compounds; D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D004338:Drug Combinations; C418365:estradiol, norethindrone drug combination; D004958:Estradiol; C050795:N,N-dimethyl-4-anisidine; C007630:estradiol 17 beta-cypionate; D009640:Norethindrone
Nuevas perspectivas para los anticonceptivos inyectables.